Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort

AIDS

Volumn 29, Issue 8, 2015, Pages 889-894

  Zhang, Yonghong ^a,b   Nejad, Shokouh Makvandi ^c   Qin, Ling ^a,b   Zhao, Yan ^a,b   Zhang, Tong ^a   Wang, Lili ^c   Repapi, Emmanouela ^c   Taylor, Stephen ^c   McMichael, Andrew ^b,c   Li, Ning ^a,b   Dong, Tao ^a,b,c   Wu, Hao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Oxford University   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

acute infection; CD4 T cell count; HIV 1; Interferon inducible transmembrane protein 3; Rs12252 C allele

Indexed keywords

MEMBRANE PROTEIN; PROTEIN INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN 3; UNCLASSIFIED DRUG; IFITM3 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADULT; ALLELE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINESE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIMARY INFECTION; PRIORITY JOURNAL; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; VIREMIA; VIRUS LOAD; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUALITY; YOUNG ADULT;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BEIJING; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA-BINDING PROTEINS; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 85003051277     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000632     Document Type: Article

References (17)

1. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139:1243 1254.
2. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 2011; 7:e1002337.
3. Jiang D, Weidner JM, Qing M, Pan XB, Guo H, Xu C, et al. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 2010; 84:8332 8341.
4. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 2011; 7:e1001258.
5. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, Guo JT. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 2010; 84:12646 12657.
6. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 2011; 85:12881 12889.
7. Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol 2013; 13:46 57.
8. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519 523.
9. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun 2013; 4:1418.
10. Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, et al. The N-Terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol 2012; 86: 13697 13707.
11. Chutiwitoonchai N, Hiyoshi M, Hiyoshi-Yoshidomi Y, Hashimoto M, Tokunaga K, Suzu S. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect 2013; 15:280 290.
12. Huang X, Chen H, Li W, Li H, Jin X, Perelson AS, et al. Precise determination of time to reach viral load set point after acute HIV-1 infection. J Acquir Immune Defic Syndr 2012; 61:448 454.
13. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-Science 2007; 317:944 947.
14. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010; 10:11 23.
15. Huang X, Lodi S, Fox Z, Li W, Phillips A, Porter K, et al. Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: A comparison between the Beijing PRIMO and CASCADE cohorts. J Acquir Immune Defic Syndr 2013; 62:441 446.
16. Williams DE, Wu WL, Grotefend CR, Radic V, Chung C, Chung YH, et al. IFITM3 polymorphism rs12252-C restricts influenza A viruses. PLoS One 2014; 9:e110096.
17. Tartour K, Fau-Appourchaux R, Appourchaux R, Fau-Gaillard J, Gaillard J, Fau-Nguyen X-N, et al. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 2014; 11:103